A common research-context setup includes the 80 mg KLOW vial(s), one 10 mL bottle of bacteriostatic water per 1-2 vials, U-100 insulin syringes (one per daily injection 30- or 50-unit syringes are easier to read for small draws), and alcohol prep pads (two per injection)
Research demonstrates that systemic IGF-1 improves healing across various tissue types including skin, ligaments, tendons, and muscle tissue
Tesamorelin has evidence for a narrow approved use, MOTS-C treatment evidence remains mostly preclinical, and retatrutide is still investigational
Thank you Susthota
This is a research schedule, not a prescription
Taurine conjugates bile acids, helping create bile salts that support fat digestion, bile secretion and the movement of cholesterol and selected compounds into the intestine